These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 14748898

  • 1. Monitoring trough plasma concentrations of mycophenolate mofetil in patients with uveitis.
    Llinares-Tello F, Hernández-Prats C, Muñoz-Ruiz C, Selva-Otaolaurruchi J, Ordovás-Baines JP.
    J Clin Pharm Ther; 2004 Feb; 29(1):53-8. PubMed ID: 14748898
    [Abstract] [Full Text] [Related]

  • 2. [Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].
    Zierhut M, Stübiger N, Aboalchamat W, Landenberger H, Bialasiewicz AA, Engelmann K.
    Ophthalmologe; 2001 Jul; 98(7):647-51. PubMed ID: 11490743
    [Abstract] [Full Text] [Related]

  • 3. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome.
    Kaplan B.
    Curr Med Res Opin; 2006 Dec; 22(12):2355-64. PubMed ID: 17257450
    [Abstract] [Full Text] [Related]

  • 5. Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.
    Daudén E, Sánchez-Peinado C, Ruiz-Genao D, García-F-Villalta M, Onate MJ, García-Díez A.
    Br J Dermatol; 2004 Jan; 150(1):132-5. PubMed ID: 14746627
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil.
    Dipchand AI, Pietra B, McCrindle BW, Rosebrook-Bicknell HL, Boucek MM.
    J Heart Lung Transplant; 2001 Oct; 20(10):1035-43. PubMed ID: 11595558
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
    Siepmann K, Huber M, Stübiger N, Deuter C, Zierhut M.
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
    [Abstract] [Full Text] [Related]

  • 8. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
    Greiner K, Varikkara M, Santiago C, Forrester JV.
    Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
    [Abstract] [Full Text] [Related]

  • 9. Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range.
    Tredger JM, Brown NW, Adams J, Gonde CE, Dhawan A, Rela M, Heaton N.
    Liver Transpl; 2004 Apr; 10(4):492-502. PubMed ID: 15048791
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring?
    Cox VC, Ensom MH.
    Ther Drug Monit; 2003 Apr; 25(2):137-57. PubMed ID: 12657908
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring.
    Meiser BM, Pfeiffer M, Schmidt D, Reichenspurner H, Ueberfuhr P, Paulus D, von Scheidt W, Kreuzer E, Seidel D, Reichart B.
    J Heart Lung Transplant; 1999 Feb; 18(2):143-9. PubMed ID: 10194038
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
    Tett SE, Saint-Marcoux F, Staatz CE, Brunet M, Vinks AA, Miura M, Marquet P, Kuypers DR, van Gelder T, Cattaneo D.
    Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
    Lobritto SJ, Rosenthal P, Bouw R, Leung M, Snell P, Mamelok RD.
    Liver Transpl; 2007 Nov; 13(11):1570-5. PubMed ID: 17969194
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic dose monitoring of mycophenolate mofetil in dermatologic diseases.
    Sokumbi O, el-Azhary RA, Langman LJ.
    J Am Acad Dermatol; 2013 Jan; 68(1):36-40. PubMed ID: 22884445
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
    Nashan B, Saliba F, Durand F, Barcéna R, Herrero JI, Mentha G, Neuhaus P, Bowles M, Patch D, Bernardos A, Klempnauer J, Bouw R, Ives J, Mamelok R, McKay D, Truman M, Marotta P.
    Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
    [Abstract] [Full Text] [Related]

  • 16. Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.
    Kuypers DR, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y.
    J Clin Pharmacol; 2003 Aug; 43(8):866-80. PubMed ID: 12953344
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and protein binding of mycophenolic acid in stable lung transplant recipients.
    Ensom MH, Partovi N, Decarie D, Dumont RJ, Fradet G, Levy RD.
    Ther Drug Monit; 2002 Apr; 24(2):310-4. PubMed ID: 11897977
    [Abstract] [Full Text] [Related]

  • 18. Clinical application of monitoring mycophenolic acid trough concentration in heart transplant recipients--single center's experience.
    Zakliczyński M, Szewczyk M, Zakliczyńska H, Zembala M.
    Ann Transplant; 2005 Apr; 10(2):38-45. PubMed ID: 16218032
    [Abstract] [Full Text] [Related]

  • 19. Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients.
    Gregoor PJ, de Sévaux RG, Hené RJ, Hesse CJ, Hilbrands LB, Vos P, van Gelder T, Hoitsma AJ, Weimar W.
    Transplantation; 1999 Nov 27; 68(10):1603-6. PubMed ID: 10589962
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil in the treatment of uveitis in children.
    Doycheva D, Deuter C, Stuebiger N, Biester S, Zierhut M.
    Br J Ophthalmol; 2007 Feb 27; 91(2):180-4. PubMed ID: 16825275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.